Bookmark
Forward
Undruggable KRAS-time to rebrand?
The Lancet Oncology
The Lancet. Oncology 2021 Mar
Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
The Lancet Oncology.
Undruggable KRAS-time to rebrand?
The Lancet. Oncology.
2021 Mar;22(3):289
Mesh Tags
Drug Discovery
Humans
Molecular Targeted Therapy
Mutation
Neoplasms
Pharmaceutical Preparations
Proto-Oncogene Proteins p21(ras)
Substances
KRAS protein, human
Pharmaceutical Preparations
Proto-Oncogene Proteins p21(ras)
PMID: 33662279
View Full Text
